EAF2 regulates DNA repair through Ku70/Ku80 in the prostate

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Androgens protect prostate cancer cells from DNA damage.
• Androgen receptor signaling regulates DNA repair genes in prostate cancer.
• ELL-associated factor 2 (EAF2) is an androgen-regulated tumor suppressor involved in DNA repair.

Purpose of the Study:

• To investigate the role of EAF2 in androgen-mediated DNA damage protection in prostate cancer.
• To elucidate the mechanism by which EAF2 influences DNA repair pathways.

Main Methods:

• Knockdown of EAF2 and EAF1 in prostate cancer cell lines.
• Assessment of DNA damage sensitivity and DNA repair marker (γH2ax) induction.
• Analysis of EAF2 expression in human prostate cancer specimens.
• Investigation of EAF2's role in Ku70/Ku80 recruitment to DNA damage sites.

Main Results:

• EAF2 knockdown sensitized prostate cancer cells and mouse prostate tissue to DNA damage.
• EAF2 deficiency did not require p53 for sensitization.
• EAF2 knockdown blocked androgen repression of doxorubicin-induced γH2ax.
• EAF2 expression inversely correlated with γH2ax levels in human prostate cancer.
• EAF2 and EAF1 are essential for Ku70/Ku80 recruitment and nonhomologous end-joining repair.

Conclusions:

• EAF2 is a key mediator of androgen-induced protection against DNA damage in prostate cancer.
• EAF2 functions by facilitating the nonhomologous end-joining DNA repair pathway via Ku70/Ku80.
• These findings highlight EAF2 as a potential therapeutic target for prostate cancer treatment.